🇺🇸 FDA
Pipeline program

AT-1501 IV Infusion

AT-1501-I206

Phase 2 mab terminated

Quick answer

AT-1501 IV Infusion for Brittle Type 1 Diabetes Mellitus is a Phase 2 program (mab) at Eledon Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Eledon Pharmaceuticals
Indication
Brittle Type 1 Diabetes Mellitus
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials